REGN vs GILD
REGN 与 GILD 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | REGNREGENERON PHARMACEUTICALS, INC. | GILDGILEAD SCIENCES, INC. |
|---|---|---|
| 市值 | — | $212.04B |
| 市盈率(TTM) | 20.5 | 25.2 |
| 市净率 | — | 16.26 |
| 市销率 | — | 7.2x |
| 股息率 | — | 1.89% |
| 营收 | $16.90B(TTM) | $30.99B(TTM) |
| 营收同比增长 | 1.0% | 2.4% |
| 净利润 | $4.82B(TTM) | -$3.86B(TTM) |
| 净利同比增长 | 2.1% | 1672.9% |
| 每股收益(稀释) | $45.24(TTM) | $-3.13(TTM) |
| 息税前利润率 | 24.9% | 34.0% |
| 净资产收益率 | 13.4% | 65.3% |
| 投入资本回报率 | 9.2% | 25.7% |
| 一年总回报 | +41.7% | +47.1% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:REGN vs GILD
| 指标 | REGN | GILD |
|---|---|---|
| 期末价值 | $26.9K | $29.7K |
| 总回报 | +169.3% | +197.3% |
| 年化收益 (CAGR) | +10.1% | +11.1% |
| 波动率 | 32.3% | 25.6% |
| 夏普比率 | 0.33 | 0.38 |
| 索提诺比率 | 0.49 | 0.56 |
| 最大回撤 | -59.7% | -30.5% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)